"These cases demonstrate that following knee and hip arthroplasty, the
use of pulsed shortwave therapy devices is feasible in both the in- and
out-patient settings and may improve analgesia while decreasing—perhaps
sometimes obviating—opioid consumption."

Full article here:

https://www.fortunejournals.com/articles/noni...series.pdf

Kelly Whelan, CEO
BioElectronics Corporation

(OTC: BIEL)